Medical specialists from France tagged as investigators in clinical trials studying Glioma
Total 87 results
-
Angelique VienotSeen in:
- Besancon, Centre Hospitalier Régional Universitaire de Besançon
- Besancon, University Hospital of Besancon
- Bourgogne-Franche-Comte, Besançon, Center Hospitalier Regional Universitaire de Besancon - Site Jean Minjoz
Trials:- NCT03678883 (Principal Investigator)
- NCT03974854 (Principal Investigator)
- NCT05948475 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Metastatic Pancreatic Adenocarcinoma;
- Cholangiocarcinoma
-
Anne Isabelle BERTOZZISeen in:
- Toulouse, CHU Toulouse
Trials:- NCT05180825 (Principal Investigator)
-
Anne Isabelle BERTOZZI SALAMON, MDSeen in:
- Toulouse, Hopital des Enfants
Trials:- NCT05476939 (Principal Investigator)
-
Anne Pagnier, MDSeen in:
- Grenoble, CHU Grenoble Alpes - Hôpital Couple-Enfant
- Grenoble, Chu Grenoble Alpes
- Grenoble, Grenoble CHU
- Isère, La Tronche, CHU GRENOBLE - Hôpital Couple-Enfant
Trials:- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02265770 (Principal Investigator)
-
Anne Ploquin, MDSeen in:
- Hauts De France, Lille, Hôpital Claude Huriez
- Lille, Hôpital Claude Huriez - Oncologie médicale
Trials:- NCT03678883 (Principal Investigator)
- NCT04811703 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma;
- Peritoneal Carcinomatosis;
- Stage IV Fallopian Tube Cancer;
- Stage IV Ovarian Cancer;
- Metastatic Ovarian Carcinoma;
- Metastatic Malignant Neoplasm in the Peritoneum;
- Stage III Ovarian Cancer;
- Stage III Fallopian Tube Cancer
-
Anne-Isabelle BERTOZZI, MDSeen in:
- Toulouse, CHU Toulouse
Trials:- NCT05394558 (Principal Investigator)
Conditions: -
Aude Marie CARDINESeen in:
- Rouen, CHU Rouen
Trials:- NCT05180825 (Principal Investigator)
-
Aurelien LambertSeen in:
- Meurthe-et-Moselle, Vandœuvre-lès-Nancy, Institute de Cancérologie de Lorraine
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Bérangère NARCISO-RAHARIMANANA, MDSeen in:
- Tours, CHRU Tours - Hopital Bretonneau
Trials:- NCT05476939 (Principal Investigator)
-
Bertrand MATHON, PhDSeen in:
- Paris, Hôpital Pitié Salpêtrière
Trials:- NCT06408428 (Principal Investigator)
-
Camille KHANFAR, MDSeen in:
- Amiens, CHU Amiens Picardie
- Amiens, CHU d'Amiens-Picardie Site Sud
- Amiens, Hopital Nord Chu Amiens
Trials:- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02870907 (Principal Investigator)
-
Carole GOURMELON, MDSeen in:
- Saint-Herblain, Institut de Cancérologie de l'Ouest
Trials:- NCT03212742 (Principal Investigator)
- NCT04762069 (Principal Investigator)
-
Céline Icher, MDSeen in:
- Bordeaux, Groupe Hospitalier Pellegrin
- Gironde, Bordeaux, CHU de Bordeaux-Hôpital des enfants Pellegrin
Trials:- NCT05180825 (Principal Investigator)
- NCT02265770 (Principal Investigator)
-
Céline ICHER de BOUYN, MDSeen in:
- Bordeaux, CHU de Bordeaux - Groupe hospitalier Pellegrin - Hôpital des enfants
Trials:- NCT05476939 (Principal Investigator)
-
Charlotte BRONNIMANN, MDSeen in:
- Bordeaux, CHU
- Bordeaux, CHU de Bordeaux - Groupe hospitalier Saint André - Hôpital Saint André
Trials:- NCT05476939 (Principal Investigator)
- NCT03212742 (Principal Investigator)
-
Chloé PUISEUXSeen in:
- Rennes, CHU Rennes - Hôpital sud
- Rennes, CHU de Rennes
- Rennes, Rennes CHU
Trials:- NCT05180825 (Principal Investigator)
- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02870907 (Principal Investigator)
-
Christian SIRE, MDSeen in:
- Lorient, GHBS
Trials:- NCT03212742 (Principal Investigator)
Conditions: -
Christophe PIGUETSeen in:
- Limoges, CHU Limoges
- Limoges, Hôpital Mère-Enfant - CHU de Limoges
- Limoges, Hôpital de la mère et de l'enfant
Trials:- NCT05180825 (Principal Investigator)
- NCT04707235 (Principal Investigator)
- NCT05476939 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT02870907 (Principal Investigator)
-
Claire BERGER, MDSeen in:
- Saint-Étienne, CHU de Saint-Etienne - Hopital Nord
- Saint-Étienne, Hopital Nord
Trials:- NCT05476939 (Principal Investigator)
- NCT05192980 (Principal Investigator)
-
Claire Briandet, MDSeen in:
- Côte d'Or, Dijon, CHU Dijon - Hôpital des Enfants
- Dijon, CHU Bocage
- Dijon, CHU Francois Mitterrand
- Dijon, DIJON CHU Hopital François Mitterand
- Dijon, DIJON Hôpital d'enfants
- Strasbourg, Service de Pédiatrie 3
Trials:- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
- NCT03690570 (Principal Investigator)
-
Cristina ALEXANDRU, MDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT03212742 (Principal Investigator)
Conditions: -
Dinu STEFAN, MDSeen in:
- Caen, Centre François Baclesse
Trials:- NCT03212742 (Principal Investigator)
Conditions: -
DOZ Francois, MDSeen in:
- Paris, Institut Curie
Trials:- NCT05394558 (Sub-Investigator)
Conditions: -
Elisabeth MOYAL COHEN-JONATHAN, PrSeen in:
- Toulouse, Institut Claudius Regaud
Trials:- NCT03212742 (Principal Investigator)
Conditions: -
Elodie VAULEON, MDSeen in:
- Rennes, Centre Eugène Marquis
Trials:- NCT05476939 (Principal Investigator)
- NCT03212742 (Principal Investigator)
-
Emilie De Carli, MDSeen in:
- Angers, CHU d'Angers
- Angers, CHU d'Angers - Bâtiment Robert Debré
- Maine-et-Loire, Angers, CHU angers
Trials:- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02265770 (Principal Investigator)
-
Emmanuel GAY, PrSeen in:
- Grenoble, Grenoble University Hospital
Trials:- NCT02077543 (Principal Investigator)
Conditions: -
Florent NEUMANN, MDSeen in:
- Dijon, CHU Dijon Bourgogne
Trials:- NCT05180825 (Principal Investigator)
Clinical Trials on Glioma
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Active, not recruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Refractory Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Refractory Glioblastoma | Refractory WHO Grade II Glioma | Refractory WHO Grade III GliomaUnited States
-
Children's Hospital of PhiladelphiaBlue Earth Diagnostics; Dragon Master FoundationNot yet recruitingGlioma | Low-grade Glioma | Glioma, Malignant | Low Grade Glioma of Brain | Glioma IntracranialUnited States
-
Children's Hospital of PhiladelphiaBlue Earth Diagnostics, Inc; Dragon Master FoundationRecruitingGlioma | High Grade Glioma | Glioma, Malignant | Diffuse Glioma | Glioma IntracranialUnited States
-
ChimerixActive, not recruitingGlioblastoma | Diffuse Midline Glioma | H3 K27M Glioma | Thalamic Glioma | Infratentorial Glioma | Basal Ganglia GliomaUnited States
-
University of California, San FranciscoBeiGene USA, Inc.; Pacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent WHO Grade III Glioma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | Low Grade Glioma | Recurrent WHO Grade II Glioma | WHO Grade II GliomaUnited States
-
National Cancer Institute (NCI)RecruitingGlioma | High Grade Glioma | Malignant Glioma | Gliomas | Low Grade GliomaUnited States
-
Beijing Tiantan HospitalDuke UniversityUnknownGlioblastoma | High Grade Glioma | Glioma, Malignant | Glioma of BrainstemChina
-
Hospital del Río HortegaCompletedGlioma | Glioblastoma | Low-grade Glioma | Glioma, Malignant | High-grade GliomaSpain
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | WHO Grade III Glioma | Recurrent Glioma | Refractory GliomaUnited States
-
Sabine Mueller, MD, PhDPacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent Grade III Glioma | Grade III GliomaUnited States, Australia, Israel, Switzerland